LOGIN 

 

JOIN

 

RENEW

Journal Club

HomeMembersAssemblies and SectionsAssembliesSleep and Respiratory NeurobiologyJournal Club ▶ The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial
The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial

Webinar date: February 13, 2019

 

Moderator
Anna M. May, MD

Presented by
Daniel Vena, PhD

Author
Luigi Taranto Montemurro, MD


Expert Panelists
David Rapoport, MD
Kingman Strohl, MD